The Use of Lepirudin for Anticoagulation in Patients with Heparin-Induced Thrombocytopenia During Major Vascular Surgery
- 1 February 2001
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 92 (2) , 344-346
- https://doi.org/10.1213/00000539-200102000-00012
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- State-of-the-Art Patient Self-Management for Control of Oral AnticoagulationSeminars in Thrombosis and Hemostasis, 1999
- Newer Strategies for the Treatment of Heparin‐Induced ThrombocytopeniaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Heparin-Induced Thrombocytopenia: A Clinicopathologic SyndromeThrombosis and Haemostasis, 1999
- Heparinoid Anticoagulation and Topical Fibrin Sealant in Heparin-Induced ThrombocytopeniaThe Annals of Thoracic Surgery, 1997
- Heparin-associated Thrombocytopenia and ThrombosisAnesthesiology, 1997
- The development of hirudin as an antithrombotic drugThrombosis Research, 1994
- Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.Journal of Clinical Investigation, 1994
- Clinical Pharmacology of Intravenously Administered Recombinant Desulfatohirudin (CGP 39393) in Healthy VolunteersJournal of Cardiovascular Pharmacology, 1993